Stuart Cobb insider trades

Open-market stock purchases and sales by Stuart Cobb, Chief Scientific Officer at Neurogene Inc, from SEC Form 4 filings since Mar 13, 2024.

Recent trades

DateStockTradeValue
Mar 13, 2026NGNE Neurogene IncSold$81.5K
Mar 13, 2026NGNE Neurogene IncSold$56.7K
Mar 13, 2026NGNE Neurogene IncSold$3.3K
Feb 20, 2026NGNE Neurogene IncBought (not open market)—

Companies traded

  • NGNE Neurogene Inc: 4 sales, last Mar 13, 2026

Get free alerts when Stuart Cobb files a new trade →